EudraLex - Volume 4 Good manufacturing practice (GMP) Guidelines.

Volume 4 of "The rules governing medicinal products in the European Union" contains guidance for the interpretation of the principles and guidelines of good manufacturing practices for medicinal products for human and veterinary use laid down in Commission Directives 91/356/EEC, as amended by Directive 2003/94/EC, and 91/412/EEC respectively.

Introduction

• Introduction(33 KB) (7/02/2011)
• Commission Directive 2003/94/EC, of 8 October 2003, laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use
  Replacement of Commission Directive 91/356/EC of 13 June 1991 to cover good manufacturing practice of investigational medicinal products.
• Commission Directive 91/412/EEC of 23 July 1991 laying down the principles and guidelines of good manufacturing practice for veterinary medicinal products.

Part I - Basic Requirements for Medicinal Products

• Chapter 1 Quality Management (revision February 2008)(29 KB)
• Chapter 2 Personnel(20 KB)
• Chapter 3 Premise and Equipment(34 KB)
• Chapter 4 Documentation (Revision January 2011) - Coming into operation by 30 June 2011(33 KB)NEW
• Chapter 5 Production(50 KB)
• Chapter 6 Quality Control (33 KB)
• Chapter 7 Contract Manufacture and Analysis(22 KB)
• Chapter 8 Complaints and Product Recall (18 KB)
• Chapter 9 Self Inspection(11 KB)

Part II - Basic Requirements for Active Substances used as Starting Materials

• Basic requirements for active substances used as starting materials(452 KB)

Part III - GMP related documents

• Site Master File (33 KB)
• Q9 Quality Risk Management
• Q10 Note for Guidance on Pharmaceutical Quality System
• MRA Batch Certificate(101 KB)NEW

Annexes

Glossary

• Glossary(27 KB)

Other documents related to GMP

• Compilation of Community Procedures on Inspections and Exchange of Information updated to include new EU formats and procedures
• Guidelines on Good Distribution Practice of Medicinal Products for Human Use (94/C 63/03)(94 KB)